Stock info Ascendis Pharma A/S | Filter  Basic-Info

Stock: Ascendis Pharma A/S (US broad)

Last Price 212.15 Max Price 217.13
Min Price 119.49 1 Year return 54.10
Sector Health Care Subsector Biotechnology

Loading...

Contact info:Country: USA

Sector Review Ascendis Pharma A/S

Loading...
Year Turnover Total sector Market share
2019 13 136,070 0.01 %
2020 7 153,065 0.00 %
2021 8 227,669 0.00 %
2022 51 260,393 0.02 %
2023 267 215,054 0.12 %

Advice Ascendis Pharma A/S

No Records Found



News Ascendis Pharma A/S

No Records Found

Annual reports Ascendis Pharma A/S

No Records Found

Profile Ascendis Pharma A/S

No Records Found

Results Ascendis Pharma A/S

Results
2021
2022
2023
2024
2025
Revenue
Costs
Profit
Margin of profit
ROI

Balance Ascendis Pharma A/S

Balance
2021
2022
2023
2024
2025
Equity
Debt
Total assets
Solvency
Cash
Cashflow
Employees
Revenue per employee
Cashflow / Debt

Details Ascendis Pharma A/S

Details
2016
2017
2018
2019
2020
Price
20.24
40.06
62.65
139.12
166.78
Eps
-2.58
-3.68
-3.17
-4.69
-8.28
Price/earnings-ratio
-7.84
-10.89
-19.76
-29.66
-25.62
Dividend
0.0
0.0
0.0
0.0
Dividend %
0.00 %
0.00 %
0.00 %
0.00 %
Payout %
0.0
0.0
0.0
0.0
Book value
5.45
5.06
6.65
12.44
15.60
Market to book
0.27
0.13
0.11
0.09
0.07
Cashflow per stock
-1.86
-2.57
-3.29
-3.67
-5.05
Stocks
32
37
42
48
54
Market Cap
656.20
1.481.59
2.639.78
6.675.78
11.403.15

Dividend Ascendis Pharma A/S

Price info Ascendis Pharma A/S

Date
Price
20 Nov 2025
212.15
19 Nov 2025
217.13
18 Nov 2025
216.56
17 Nov 2025
204.40
15 Nov 2025
204.40
13 Nov 2025
199.22
12 Nov 2025
201.16
11 Nov 2025
196.01
06 Nov 2025
197.75
05 Nov 2025
208.24
04 Nov 2025
200.98
29 Oct 2025
205.91
23 Oct 2025
200.59
18 Oct 2025
210.50
09 Oct 2025
210.13
03 Oct 2025
200.97
30 Sep 2025
191.60
22 Sep 2025
197.68
16 Sep 2025
194.62
08 Sep 2025
205.91
01 Sep 2025
194.27
21 Aug 2025
192.80
15 Aug 2025
192.04
08 Aug 2025
191.49
07 Aug 2025
190.35
06 Aug 2025
182.60
05 Aug 2025
186.59
04 Aug 2025
184.15
01 Aug 2025
174.48
31 Jul 2025
173.50
Overig aandelennieuws
Ascendis Pharma A/S Announces Upcoming Investor Presentation in November
Ascendis Pharma A/S Announces Third Quarter 2019 Financial Results and Business Update Conference Call on November 18
Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe
Ascendis Pharma A/S Announces Presentations on Achondroplasia and TransCon™ CNP at International Skeletal Dysplasia Society Meeting
Ascendis Pharma A/S Announces Three Investor Presentations in September
Ascendis Pharma A/S Reports Second Quarter 2019 Financial Results
Ascendis Pharma A/S Announces Second Quarter 2019 Financial Results and Business Update Conference Call on August 28
Analist
Returns European stocks
Crypto currencies information
About us Network Partners
Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2025 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo